A New Trend of Digital Healthcare in 3D Printed Medicines


  •  Itimad Raheem Ali    
  •  Jwan K. Alwan    
  •  Dhulfiqar Saad Jaafar    
  •  Hoshang Kolivand    

Abstract

Three-dimensional ‎(‎3D) technique of restricting scrambling is changing the ways of drug design, labeling and ‎production in the area of ‎digital health. By combining digital and genetic techniques, Fused ‎Deposition Modeling (FDM) can manufacture ‎normalization systems. Consecutively, such a ‎method can allow for speedy improvements in the healthcare ‎systems, allowing the allocation ‎of medicines based on patient’s needs and requirements. So far, several 3D ‎based medicinal ‎goods have been marketed. These include the production of implants and several useful related ‎‎products for use in medical applications. Nevertheless, regulatory obstacles remain with ‎developing medicines. ‎This article reviews the latest FDM technology in medical and ‎pharmaceutical research, including a discussion of ‎the potential challenges in the field. ‎Emphasis has been paid on future developments needed for facilitating the ‎FDM integration ‎into dispensaries and clinics.‎


This work is licensed under a Creative Commons Attribution 4.0 License.
  • ISSN(Print): 1913-8989
  • ISSN(Online): 1913-8997
  • Started: 2008
  • Frequency: quarterly

Journal Metrics

WJCI (2020): 0.439

Impact Factor 2020 (by WJCI): 0.247

Google Scholar Citations (March 2022): 6907

Google-based Impact Factor (2021): 0.68

h-index (December 2021): 37

i10-index (December 2021): 172

(Click Here to Learn More)

Contact